Login / Signup

Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study).

Kin Seng LiemScott FungDavid K WongColina YimSeham NoureldinJiayun ChenJordan J FeldBettina E HansenHarry L A Janssen
Published in: Gut (2019)
NCT01911156.
Keyphrases
  • hepatitis b virus
  • molecular docking